Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2012

01.08.2012 | Original Paper

Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X)

verfasst von: Peter Ong, Anastasios Athanasiadis, Heiko Mahrholdt, Gabor Borgulya, Udo Sechtem, Juan Carlos Kaski

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims

Cardiac syndrome X (CSX) is characterized by exercise-induced angina, positive exercise stress-test responses and angiographically normal coronary arteries. The condition characteristically affects more women than men and is often associated with coronary microvascular dysfunction, i.e., abnormal vasodilatory responses. Recent clinical observations suggest that increased coronary vasoconstriction may have a pathogenic role in CSX. We therefore sought to assess the prevalence of increased epicardial and microvascular coronary vasoconstriction in women with CSX.

Methods and results

Among 1,120 consecutive women with angina undergoing diagnostic coronary angiography 39 fulfilled criteria for CSX (mean age 63 ± 9 years) and were included in the study (27 also complained about rest angina). Five women without angina (mean age 64 ± 24 years) and normal coronary arteriograms served as controls. Patients and controls underwent intracoronary acetylcholine testing with a standardized protocol. Severe (≥75 % diameter reduction) epicardial constriction developed in 12 CSX patients (31 %) with reproduction of their angina in 10. All 12 patients showed diffuse epicardial constriction affecting mainly the distal coronary segments. Twenty-two CSX patients (56 %) experienced their usual angina without epicardial constriction of which 21 had ischemic ECG shifts. The remaining five CSX patients (13 %) had no angina or constriction in response to acetylcholine. None of the control patients had angina or constriction during ACH testing.

Conclusion

Increased epicardial as well as microvascular coronary constriction in response to acetylcholine are frequent findings in women with CSX. The results indicate that inappropriate coronary constriction is likely to contribute to the anginal symptoms of these patients. The ACH-test may be useful in the clinical setting to unmask this vasomotor disorder.
Literatur
1.
Zurück zum Zitat Kaski JC (2004) Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 109:568–572PubMedCrossRef Kaski JC (2004) Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 109:568–572PubMedCrossRef
2.
Zurück zum Zitat Patel MR, Peterson ED, Dai D et al (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362:886–895PubMedCrossRef Patel MR, Peterson ED, Dai D et al (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362:886–895PubMedCrossRef
3.
Zurück zum Zitat Cannon RO 3rd, Epstein SE (1988) “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 61:1338–1343PubMedCrossRef Cannon RO 3rd, Epstein SE (1988) “Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 61:1338–1343PubMedCrossRef
4.
Zurück zum Zitat Crea F, Lanza GA (2004) Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 90:457–463PubMedCrossRef Crea F, Lanza GA (2004) Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 90:457–463PubMedCrossRef
5.
Zurück zum Zitat Infusino F, Lanza GA, Sestito A et al (2009) Combination of variant and microvascular angina. Clin Cardiol 32:E40–E45PubMedCrossRef Infusino F, Lanza GA, Sestito A et al (2009) Combination of variant and microvascular angina. Clin Cardiol 32:E40–E45PubMedCrossRef
6.
Zurück zum Zitat Yilmaz A, Hill S, Schäufele T et al (2010) Exercise-induced spastic coronary artery occlusion at the site of a moderate stenosis: neither Prinzmetal’s angina nor cardiac syndrome X but “Prinzmetal X”. Circulation 122:e570–e574PubMedCrossRef Yilmaz A, Hill S, Schäufele T et al (2010) Exercise-induced spastic coronary artery occlusion at the site of a moderate stenosis: neither Prinzmetal’s angina nor cardiac syndrome X but “Prinzmetal X”. Circulation 122:e570–e574PubMedCrossRef
7.
Zurück zum Zitat Kaski JC, Rosano GM, Collins P et al (1995) Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 25:807–814PubMedCrossRef Kaski JC, Rosano GM, Collins P et al (1995) Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 25:807–814PubMedCrossRef
8.
Zurück zum Zitat Lanza GA, Manzoli A, Pasceri V et al (1997) Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing. Am J Cardiol 79:1–6PubMedCrossRef Lanza GA, Manzoli A, Pasceri V et al (1997) Ischemic-like ST-segment changes during Holter monitoring in patients with angina pectoris and normal coronary arteries but negative exercise testing. Am J Cardiol 79:1–6PubMedCrossRef
9.
Zurück zum Zitat Ong P, Athanasiadis A, Hill S et al (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 52:523–527PubMedCrossRef Ong P, Athanasiadis A, Hill S et al (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol 52:523–527PubMedCrossRef
10.
Zurück zum Zitat Lüscher TF, Pieper M, Tendera M et al (2009) A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. Eur Heart J 30:1590–1597PubMedCrossRef Lüscher TF, Pieper M, Tendera M et al (2009) A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. Eur Heart J 30:1590–1597PubMedCrossRef
11.
Zurück zum Zitat Sueda S, Mineoi K, Kondo T et al (1998) Absence of induced spasm by intracoronary injection of 50 micrograms acetylcholine in the right coronary artery: usefulness of 80 micrograms of acetylcholine as a spasm provocation test. J Cardiol 32:155–161PubMed Sueda S, Mineoi K, Kondo T et al (1998) Absence of induced spasm by intracoronary injection of 50 micrograms acetylcholine in the right coronary artery: usefulness of 80 micrograms of acetylcholine as a spasm provocation test. J Cardiol 32:155–161PubMed
12.
Zurück zum Zitat Austen WG, Edwards JE, Frye RL et al (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51(4 Suppl):5–40PubMedCrossRef Austen WG, Edwards JE, Frye RL et al (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51(4 Suppl):5–40PubMedCrossRef
13.
Zurück zum Zitat Mohri M, Koyanagi M, Egashira K et al (1998) Angina pectoris caused by coronary microvascular spasm. Lancet 351:1165–1169PubMedCrossRef Mohri M, Koyanagi M, Egashira K et al (1998) Angina pectoris caused by coronary microvascular spasm. Lancet 351:1165–1169PubMedCrossRef
14.
Zurück zum Zitat Sun H, Mohri M, Shimokawa H et al (2002) Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 39:847–851PubMedCrossRef Sun H, Mohri M, Shimokawa H et al (2002) Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 39:847–851PubMedCrossRef
15.
Zurück zum Zitat Levene DL, Freeman MR (1976) Alpha-adrenoceptor-mediated coronary artery spasm. JAMA 236:1018–1022PubMedCrossRef Levene DL, Freeman MR (1976) Alpha-adrenoceptor-mediated coronary artery spasm. JAMA 236:1018–1022PubMedCrossRef
16.
Zurück zum Zitat Specchia G, de Servi S, Falcone C et al (1979) Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation 59:948–954PubMedCrossRef Specchia G, de Servi S, Falcone C et al (1979) Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation 59:948–954PubMedCrossRef
17.
Zurück zum Zitat Waters DD, Szlachcic J, Bonan R et al (1983) Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 67:310–315PubMedCrossRef Waters DD, Szlachcic J, Bonan R et al (1983) Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 67:310–315PubMedCrossRef
18.
Zurück zum Zitat Boden WE, Bough EW, Korr KS et al (1981) Exercise-induced coronary spasm with S-T segment depression and normal coronary arteriography. Am J Cardiol 48:193–197PubMedCrossRef Boden WE, Bough EW, Korr KS et al (1981) Exercise-induced coronary spasm with S-T segment depression and normal coronary arteriography. Am J Cardiol 48:193–197PubMedCrossRef
19.
Zurück zum Zitat Sacknoff DM, Wilentz JR, Schiffer MB et al (1993) Exercise-induced ST-segment depression: relationship to nonocclusive coronary artery spasm. Am Heart J 125:242–244PubMedCrossRef Sacknoff DM, Wilentz JR, Schiffer MB et al (1993) Exercise-induced ST-segment depression: relationship to nonocclusive coronary artery spasm. Am Heart J 125:242–244PubMedCrossRef
20.
Zurück zum Zitat Coma-Canella I, Castano S, Macías A et al (2006) Ergonovine test in angina with normal coronary arteries. Is it worth doing it? Int J Cardiol 107:200–206PubMedCrossRef Coma-Canella I, Castano S, Macías A et al (2006) Ergonovine test in angina with normal coronary arteries. Is it worth doing it? Int J Cardiol 107:200–206PubMedCrossRef
21.
Zurück zum Zitat Lanza GA (2007) Cardiac syndrome X: a critical overview and future perspectives. Heart 93:159–166PubMedCrossRef Lanza GA (2007) Cardiac syndrome X: a critical overview and future perspectives. Heart 93:159–166PubMedCrossRef
22.
Zurück zum Zitat Gross L, Epstein EZ, Kugel MA (1934) Histology of the coronary arteries and their branches in the human heart. Am J Pathol 10(253–274):7PubMed Gross L, Epstein EZ, Kugel MA (1934) Histology of the coronary arteries and their branches in the human heart. Am J Pathol 10(253–274):7PubMed
23.
Zurück zum Zitat Egashira K, Suzuki S, Hirooka Y et al (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25:201–206PubMedCrossRef Egashira K, Suzuki S, Hirooka Y et al (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25:201–206PubMedCrossRef
24.
Zurück zum Zitat Toda N (1983) Isolated human coronary arteries in response to vasoconstrictor substances. Am J Physiol 245:H937–H941PubMed Toda N (1983) Isolated human coronary arteries in response to vasoconstrictor substances. Am J Physiol 245:H937–H941PubMed
25.
Zurück zum Zitat Thorin E (2001) Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol 38:90–98PubMedCrossRef Thorin E (2001) Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol 38:90–98PubMedCrossRef
26.
Zurück zum Zitat el-Tamimi H, Mansour M, Wargovich TJ et al (1994) Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited. Circulation 89:45–51PubMedCrossRef el-Tamimi H, Mansour M, Wargovich TJ et al (1994) Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited. Circulation 89:45–51PubMedCrossRef
27.
Zurück zum Zitat Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, SCAST (Statin and Coronary Artery Spasm Trial) Investigators (2008) Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 51:1742–1748PubMedCrossRef Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, SCAST (Statin and Coronary Artery Spasm Trial) Investigators (2008) Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 51:1742–1748PubMedCrossRef
28.
Zurück zum Zitat Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Merz CN, Pepine CJ (2011) In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J 162:678–684PubMedCrossRef Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Merz CN, Pepine CJ (2011) In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J 162:678–684PubMedCrossRef
29.
Zurück zum Zitat Pizzi C, Manfrini O, Fontana F, Bugiardini R (2004) Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation 109:53–58PubMedCrossRef Pizzi C, Manfrini O, Fontana F, Bugiardini R (2004) Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation 109:53–58PubMedCrossRef
30.
Zurück zum Zitat Nielsen H, Egeblad H, Mortensen SA et al (1987) Observations on increased susceptibility to coronary artery vasospasm during beta blockade. Am Heart J 114:192–194PubMedCrossRef Nielsen H, Egeblad H, Mortensen SA et al (1987) Observations on increased susceptibility to coronary artery vasospasm during beta blockade. Am Heart J 114:192–194PubMedCrossRef
31.
Zurück zum Zitat Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, Sakuma T, Nagashima K, Kato K (1989) Effect of nicorandil on coronary spasm. Am J Cardiol 63:75J–79JPubMedCrossRef Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, Sakuma T, Nagashima K, Kato K (1989) Effect of nicorandil on coronary spasm. Am J Cardiol 63:75J–79JPubMedCrossRef
32.
Zurück zum Zitat Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, Bairey Merz CN (2011) Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 4:514–522PubMedCrossRef Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, Bairey Merz CN (2011) Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 4:514–522PubMedCrossRef
33.
Zurück zum Zitat Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G, Ellahham S, Quyyumi AA (2002) The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 40:1232–1240PubMedCrossRef Halcox JP, Nour KR, Zalos G, Mincemoyer RA, Waclawiw M, Rivera CE, Willie G, Ellahham S, Quyyumi AA (2002) The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 40:1232–1240PubMedCrossRef
34.
Zurück zum Zitat Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO, Lerman A (2010) Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation 122:958–966PubMedCrossRef Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO, Lerman A (2010) Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation 122:958–966PubMedCrossRef
35.
Zurück zum Zitat Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109:2518–2523PubMedCrossRef Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109:2518–2523PubMedCrossRef
36.
Zurück zum Zitat Kaski JC (2002) Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 53:620–626PubMedCrossRef Kaski JC (2002) Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 53:620–626PubMedCrossRef
37.
Zurück zum Zitat Vaccarino V, Badimon L, Corti R et al (2011) Ischemic heart disease in women: are there sex differences in pathophysiology and risk factors?: Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 90:9–17 Vaccarino V, Badimon L, Corti R et al (2011) Ischemic heart disease in women: are there sex differences in pathophysiology and risk factors?: Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 90:9–17
38.
Zurück zum Zitat Vermeltfoort IA, Raijmakers PG, Riphagen II, Odekerken DA, Kuijper AF, Zwijnenburg A, Teule GJ (2010) Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol 99:475–481PubMedCrossRef Vermeltfoort IA, Raijmakers PG, Riphagen II, Odekerken DA, Kuijper AF, Zwijnenburg A, Teule GJ (2010) Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol 99:475–481PubMedCrossRef
Metadaten
Titel
Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X)
verfasst von
Peter Ong
Anastasios Athanasiadis
Heiko Mahrholdt
Gabor Borgulya
Udo Sechtem
Juan Carlos Kaski
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2012
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-012-0442-4

Weitere Artikel der Ausgabe 8/2012

Clinical Research in Cardiology 8/2012 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.